Viatris (VTRS) Dividend Coverage Ratio (2021 - 2026)
Viatris (VTRS) posted Dividend Coverage Ratio of 0.85 for Q2 2026, down 167.25% on a QoQ basis from 1.26 in Q1 2026, and down 2482.61% year-over-year from 0.04 in Q2 2025.
Analysis
Viatris (VTRS) Dividend Coverage Ratio (2021 - 2026) Analysis & Trends
Viatris has reported Dividend Coverage Ratio for 6 years, with the latest figure at 0.85 in Q2 2026.
- On a quarterly basis, Dividend Coverage Ratio fell 2482.61% year-over-year to 0.85 in Q2 2026; TTM through Jun 2026 was 0.74, a 87.9% increase from a year earlier, with the FY2025 full-year figure at 6.26, down 467.66% from the prior year.
- Dividend Coverage Ratio was 0.85 for Q2 2026 at Viatris, down from 1.26 in the prior quarter.
- The five-year high for Dividend Coverage Ratio was 6.95 in Q4 2022, with the low at 21.23 in Q1 2025.
- Average Dividend Coverage Ratio over 5 years is 0.77, with a median of 0.73 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Dividend Coverage Ratio soared 450.39% in 2022, then sank 2761.45% in 2025.
- Over 5 years, Dividend Coverage Ratio stood at 6.95 in 2022, then slumped by 176.5% to 5.32 in 2023, then jumped by 32.21% to 3.6 in 2024, then surged by 31.72% to 2.46 in 2025, then surged by 65.47% to 0.85 in 2026.
- The last three Dividend Coverage Ratio figures came in at 0.85 (Q2 2026), 1.26 (Q1 2026), and 2.46 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.98 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -0.85 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 522.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.65 Mn | 365.40 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.85 |
| Mar 31, 2026 | 1.26 |
| Dec 31, 2025 | -2.46 |
| Sep 30, 2025 | -0.92 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -21.23 |
| Dec 31, 2024 | -3.60 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | -2.24 |
| Mar 31, 2024 | 0.80 |
| Dec 31, 2023 | -5.32 |
| Sep 30, 2023 | 2.30 |
| Jun 30, 2023 | 1.83 |
| Mar 31, 2023 | 1.56 |
| Dec 31, 2022 | 6.95 |
| Sep 30, 2022 | 2.44 |
| Jun 30, 2022 | 2.16 |
| Mar 31, 2022 | 2.75 |
| Dec 31, 2021 | -1.98 |
| Sep 30, 2021 | 2.34 |